Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
65 hedge funds and large institutions have $193M invested in Syneron Medical Ltd in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 18 reducing their positions, and 7 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
7% more capital invested
Capital invested by funds: $181M → $193M (+$12.7M)
7% more funds holding
Funds holding: 61 → 65 (+4)
17% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 18
99% less call options, than puts
Call options by funds: $1K | Put options by funds: $117K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
+$6.26M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$6M |
| 3 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$3.52M |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$1.53M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$6.36M |
| 2 |
SAM
Senzar Asset Management
New York
|
-$5.4M |
| 3 |
IAM
Ion Asset Management
Herzliya,
Israel
|
-$1.63M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.58M |
| 5 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$1.15M |
ELOS Hedge Fund Activity: Q2 2016 in Review
65 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q2 2016, worth a combined $193M — up 7% from $181M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ELOS positions and 7 closed out — a net gain of 4 holders — while 15 added to existing stakes and 18 trimmed.
The largest buyer was Migdal Insurance & Financial Holdings, opening a new position worth an estimated $6.26M. The largest seller was Broadfin Capital, exiting entirely with an estimated $6.36M sold.
- 65 institutional investors held Syneron Medical Ltd (ELOS) as of Q2 2016, up from 61 in Q1 2016.
- Funds reported $193M of Syneron Medical Ltd stock for Q2 2016, up 7% quarter-over-quarter.
- 11 funds opened new Syneron Medical Ltd positions in Q2 2016 and 7 closed out, a net change of +4 holders.
- The largest Syneron Medical Ltd buyer in Q2 2016 was Migdal Insurance & Financial Holdings, an estimated $6.26M added.
- The largest Syneron Medical Ltd seller in Q2 2016 was Broadfin Capital, an estimated $6.36M sold.
Based on aggregated 13F filings for Q2 2016.